Biogen Says Government Is Probing Its Drug Prices, Rebates, Buyer Assist Efforts

(July 22, 2016, 10:38 AM EDT) -- CAMBRIDGE, Mass. — Biotechnology company Biogen Inc. said July 21 that it received civil investigative demands on July 1 from the federal government for documents and information relating to the company’s...
To view the full article, register now.